Glasgow/Wetlab/Week1
From 2007.igem.org
(Difference between revisions)
m (Made table out of BB list) |
(→Thursday 5th July 2007) |
||
Line 45: | Line 45: | ||
|[http://partsregistry.org/Part:BBa_P1010 Bba_p1010] || Construction plasmid || ''E. coli'' DB3.1 || pSB1A10 || 4/7A | |[http://partsregistry.org/Part:BBa_P1010 Bba_p1010] || Construction plasmid || ''E. coli'' DB3.1 || pSB1A10 || 4/7A | ||
|- align="center" | |- align="center" | ||
- | | || || || pSB1A10 || 4/11E | + | | " || " || " || pSB1A10 || 4/11E |
|- align="center" | |- align="center" | ||
- | | || || || pSB3K3 || 4/11C | + | | " || " || " || pSB3K3 || 4/11C |
|- align="center" | |- align="center" | ||
|[http://partsregistry.org/Part:BBa_I52001 Bba_I52001] || High copy-number construction plasmid || ''E. coli'' TOP10 <br> <font color="red">should have been DB3.1</font> || pSB4A5 || 4/5I | |[http://partsregistry.org/Part:BBa_I52001 Bba_I52001] || High copy-number construction plasmid || ''E. coli'' TOP10 <br> <font color="red">should have been DB3.1</font> || pSB4A5 || 4/5I | ||
|- align="center" | |- align="center" | ||
- | | || || || pSB4K5 || 4/5D | + | | " || " || " || pSB4K5 || 4/5D |
|- align="center" | |- align="center" | ||
- | | || || || pSB4K5 || 4/6D | + | | " || " || " || pSB4K5 || 4/6D |
|- align="center" | |- align="center" | ||
- | | || || || pSB3K5 || 4/6B | + | | " || " || " || pSB3K5 || 4/6B |
|- align="center" | |- align="center" | ||
- | | || || || pSB4A5 || 4/6E | + | | " || " || " || pSB4A5 || 4/6E |
|- align="center" | |- align="center" | ||
|[http://partsregistry.org/Part:BBa_J23119 Bba_J23119] || Strong constitutive promoter || ''E. coli'' TOP10 || pSB1A2 || 3/19A | |[http://partsregistry.org/Part:BBa_J23119 Bba_J23119] || Strong constitutive promoter || ''E. coli'' TOP10 || pSB1A2 || 3/19A |
Revision as of 23:17, 15 August 2007
Glasgow Main Page | Back To Wetlab Log
Contents |
Week 1
Tuesday 3rd July 2007
- Maija and Christine prepared LB broth and LB agar with Protocol 1. Made 4 batches of plates, 2 with kanamycin and 2 with carbenicillin.
Wednesday 4th July 2007
- All wetlab researched BioBricks.
- Reporter constructs and mini-Tn5 stocks looked out.
- Streaked the following:
- P. putida PAW 340 pJAK14 (Carb. plate)
- Tn5 lux AB (Carb. plate)
- Mini-Tn5 lux AB (Carb. plate)
- P. fluorescens NCIMB 9815 (Carb. plate)
- P. putida KT2440 (LB)
- JM109 pBluescript 5k+ (Carb. plate)
- Mini-Tn5 Tc (Carb. Plate)
- pQF52 (Carb. plate)
- P. fluorescens 9815 (LB)
- E. coli pJAK14 (Km plate)
- Il DntR in pOF52 (Carb. plate)
- pUCINR in Ω strain C (Carb. plate)
- pGLTUR (Carb. plate)
- Mini-Tn5 Kan (Carb. plate)
- Mini-Tn5 Sm/Sp (Carb. plate)
- Mini-Tn5 1cc2 (Carb. plate)
- E. coli Sa1 (LB)
- DmpR #24 (Carb. plate)
- Mini-Tn5 lac 32 in E. coli 517 (Carb. plate)
- Mini-Tn5 Tc (Carb. Plate)
- Mini-Tn5 Cm (Carb. plate)
- DmpR WT (Carb. plate)
- E.coli sm 10 pESD15 Tn5 GFP (Carb. plate)
- pUJ8 (Carb. Plate)
Thursday 5th July 2007
- BioBricks – Maija and Scott transformed using Protocol 2.
BioBrick Part Function Chassis Plasmid Kit Plate Location (Plate/Well) Bba_p1010 Construction plasmid E. coli DB3.1 pSB1A10 4/7A " " " pSB1A10 4/11E " " " pSB3K3 4/11C Bba_I52001 High copy-number construction plasmid E. coli TOP10
should have been DB3.1pSB4A5 4/5I " " " pSB4K5 4/5D " " " pSB4K5 4/6D " " " pSB3K5 4/6B " " " pSB4A5 4/6E Bba_J23119 Strong constitutive promoter E. coli TOP10 pSB1A2 3/19A Bba_R0062 HSL & LuxR-inducible promoter E. coli TOP10 pSB1A2 1/9G Bba_J04500 IPTG-inducible promoter + RBS E. coli TOP10 pSB1AK3 1/16P Bba_E0040 Promoter-less GFP E. coli TOP10 pSB1A2 1/5H - Maia and Christine researched restriction enzymes for the reporter constructs and Mini-Tn5s streaked on 4/7/07 and digested some. Had planned to make biobricks using Mini-Tn5s etc but discovered that a previous attempt to use transposable elements to make biobricks had been unsuccessful due to scarring at the restriction site.
Friday 6th July 2007
- Maija and Christine made 10x stocks for M9 (see Protocol 3.2 - M9).
- Tutorial in BioEdit and Primer3.
- Started designing primers for amplification and site directed mutagenesis of DmpR and DmpR #24 (see Protocol 4).